Core Viewpoint - The company reports a 10% year-over-year revenue growth driven by HiFi sequencing technology, with strong international growth in APAC (+53%) and EMEA (+35%) regions, maintaining full-year revenue guidance of $155 million to $165 million, representing a midpoint growth of 1-7% [2] Financial Performance Analysis - Q2 revenue reached $39.8 million, reflecting a 7% quarter-over-quarter and 10% year-over-year increase [3] - Revenue breakdown: Instrument revenue at $14.2 million (down 4% YoY), Consumables at $18.9 million (up 11% YoY), and Service revenue at $6.7 million (up 57% YoY) [3] - Non-GAAP gross margin improved to 38.3%, exceeding expectations due to higher consumables profit margins [3] - Cash balance stands at $315 million, above expectations, with projected annual cash burn of $115 million, an improvement of $72 million YoY [3] Key Drivers - Revenue growth is primarily driven by international expansion (combined APAC/EMEA growth of 45%) and new customers for the Vega system (60% from new clients) [4] - Ongoing uncertainty in U.S. academic funding continues to suppress instrument demand, while consumables show resilience [4] - Cost optimization measures led to an 18% year-over-year reduction in operating expenses [4] Business Operations - The Revio system has a cumulative deployment of 297 units (15 new units in Q2), with 60% targeting new customers and one-third entering clinical laboratories [5] - The Vega system has a cumulative deployment of 73 units (38 new units in Q2), with 70% used for non-whole genome applications (e.g., microbiome sequencing) [5] - Consumables account for 15% of clinical revenue, with clients like Quest entering commercialization [5] Technological Innovation - The Spark chemical reagent has improved throughput by 33% and reduced sequencing costs, now covering 90% of operations [6] - Multi-purpose intelligent cells (in development) are expected to lower customer costs and enhance company gross margins [6] Market Expansion - Strong international growth includes rare disease research in Nordic hospitals and population sequencing projects in Southeast Asia [8] - Collaborative cases include Haorai Gene in China promoting transfusion medicine applications and Target ALS for global genomic research [8] Future Outlook and Planning - Short-term goals for 2025 include maintaining revenue guidance of $155 million to $165 million, with double-digit growth in consumables offsetting instrument declines [9] - Targeting non-GAAP gross margin improvement to 37-40% (with expectations to exceed 40% by year-end) and controlling operating expenses between $235 million and $240 million [9] Mid to Long-term Strategy - Aiming for positive cash flow by 2027 [10] - Plans to expand clinical and population genomics markets through HiFi technology and multi-omics solutions [10] CEO Insights - The CEO emphasizes the unique advantages of HiFi technology (long reads and simultaneous epigenetic detection) and aims to lower adoption barriers through innovation [11] - Reiterates financial discipline and focuses on clinical translation and scale effects, with a goal to become a leader in genomic medicine [11]

导读： 精灵生命完成近亿元天使轮融资，用于LASE光谱影像流式细胞仪开发，推动国产高端流式技术全球普及。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 专注于影像流式细胞仪原创研发的精灵生命科学（武汉）有限公司（以下简称：精灵生命）近日完成近亿元天使轮融资。本轮融资由明熙资本 和君联资本联合领投、湖北科投跟投，资金将用于公司独创的 LASE（Linear Array Spot Excitation） 光谱影像流式细胞仪 的开发，推 动国产高端流式技术的全球普及。 创始人赵精晶本科毕业于北京理工大学，拥有清华大学与斯坦福大学背景，曾参与国家首个科技重大专项"流式细胞仪"项目，拥有十余年相关 技术研发经验。核心团队成员来自斯坦福大学、清华大学、华中科技大学等顶尖高校，涵盖光学、微纳制造、成像算法等多个领域，具备从原 理设计到系统工程的全链路研发能力。 特别是2025年初，美国政府已将"高参数流式细胞仪"列入出口管制清单，背后正是该设备在人工智能训练、生物设计等新兴领域的核心战略 价值，国产替代迫在眉睫。 精灵生命正是在这一背景下切入流式细胞仪 ...

Core Viewpoint - Jiangnan University has announced multiple government procurement intentions for laboratory instruments, with a total budget of 83.34 million yuan, covering 40 items including advanced analytical and testing equipment [2]. Summary by Categories Procurement Overview - The procurement plan includes a variety of sophisticated instruments such as intelligent biological manufacturing multi-scale analysis systems, atomic force microscopes, ultra-high performance liquid chromatography systems, and high-content imaging systems, with expected procurement time from March to October 2025 [2][4]. Specific Instruments and Their Functions - Intelligent Biological Manufacturing Multi-Scale Analysis System: Aimed at real-time monitoring and data integration for biological catalytic material synthesis and separation processes [4]. - Atomic Force Microscope: Designed for high-resolution 3D morphology testing and analysis of various material properties at micro and nano scales [4]. - Ultra-High Performance Liquid Chromatography Systems: Approximately three units will be procured for precise separation and quantitative analysis of various components in food and biological samples [5]. - Confocal Raman Spectrometer: Intended for non-destructive testing of food components and microstructural analysis, addressing urgent needs in food safety and quality control [5]. Budget and Timeline - The total budget for the procurement is 83.34 million yuan, with the procurement expected to take place between March and October 2025 [2][4].

Core Viewpoint - The industrial non-destructive testing (NDT) sector has achieved a significant technological breakthrough with the launch of a portable X-ray stress analyzer by the company, addressing challenges faced by traditional equipment [3][56]. Group 1: Technological Advancements - The new portable X-ray stress analyzer utilizes photon counting area detection technology, marking a new development stage in stress detection technology [3]. - This innovative product offers advantages such as being compact, fast, accurate, and cost-effective, effectively solving issues related to size, ease of operation, overall cost, and measurement efficiency in traditional stress detection equipment [3][26]. Group 2: Comparison with Traditional Methods - Traditional X-ray stress analyzers require complex setups and multiple angle measurements, making them bulky and difficult to use in active scenarios [15]. - The new analyzer simplifies operations by allowing complete stress detection in a single exposure without the need for angle measurement devices, significantly improving efficiency [15][30]. Group 3: Key Features of the New Analyzer - The analyzer features a lightweight and compact design, making it suitable for various complex environments, thus functioning as a "mobile detection station" [29]. - It employs advanced Cosα technology and photon counting detectors, which enhance imaging quality and data accuracy, surpassing traditional X-ray detectors [22][24]. - The system is fully domestically developed, ensuring long-term safety and stable supply for users [25]. Group 4: Applications and Market Potential - The analyzer is crucial for stress detection in key industrial structures, such as gear transmission systems, welded structures, and bolted connections, where stress concentration can lead to early damage or structural failure [37]. - It is applicable in various industries, including metal manufacturing, energy, petrochemicals, transportation, aerospace, and shipbuilding, highlighting the widespread demand for stress detection [51]. Group 5: Collaboration Opportunities - The company invites partnerships with industry solution providers, channel distributors, and large testing service organizations to promote the adoption of this advanced detection technology [52][54].

Core Viewpoint - Huazhong University of Science and Technology has announced procurement intentions for 35 types of instruments and equipment, with a total budget of 133 million yuan, expected to be procured between June and October 2025 [2][3]. Instrument Procurement Summary - The procurement includes various advanced instruments such as phase noise analyzers, metallographic microscopes, power device analyzers, plasma-enhanced chemical vapor deposition systems, and high-bandwidth high-speed time-domain signal modulation analyzers [3][4][5][6]. Detailed Instrument Descriptions - **Metallographic Microscope**: Used for observing and analyzing the microstructure of metals and other materials, crucial for understanding material properties and processing [4]. - **Power Device Analyzer**: Designed for testing and evaluating the performance of power semiconductor devices, widely used in power electronics [5]. - **Plasma-Enhanced Chemical Vapor Deposition System**: Utilizes plasma to deposit thin films at lower temperatures, suitable for temperature-sensitive materials [6]. Procurement Budget Overview - The total budget for the procurement is 133 million yuan, with specific allocations for various instruments, including: - Olink Explore HT proteomics detection service: 4.23 million yuan [8]. - Precision components and emergency mechanisms: 1.1 million yuan [10]. - High-speed time-domain signal modulation analyzer: 3.5 million yuan [12]. - Phase noise analyzer: 1.68 million yuan [13]. Research and Development Strength - Huazhong University is recognized for its strong research capabilities, particularly in engineering, biomedical engineering, and materials science, contributing significantly to national technological advancements [15][16][17].

Core Viewpoint - The article emphasizes the establishment of a national carbon measurement center by 2030, focusing on key industries and areas, enhancing carbon measurement policies, and strengthening technological innovation in carbon measurement [2][3][4]. Summary by Sections Overall Requirements - The national carbon measurement center aims to support China's sustainable economic development and achieve carbon peak and carbon neutrality goals by 2030, relying on measurement technology institutions, research institutes, universities, and central enterprises [8]. Main Tasks - **Policy Research**: Strengthening research on carbon measurement policies and requirements to support regulatory measures [9]. - **Establishing Traceability System**: Developing a carbon measurement traceability system, including continuous monitoring systems for CO2 emissions and enhancing the capability to produce standard substances [9][10]. - **Technical Research and Application**: Accelerating research on key measurement technologies related to low-carbon development and improving the quality of carbon measurement instruments [10]. - **Verification Capability**: Building platforms for practical carbon measurement and improving the accuracy of carbon emission factors [11]. - **Technical Services**: Providing various technical services related to carbon measurement, including calibration and data quality evaluation [11]. - **Data Analysis and Application**: Enhancing data collection and analysis in key industries to create a comprehensive carbon measurement system [12]. - **International Cooperation**: Engaging in international carbon measurement technology research and promoting cooperation with countries along the Belt and Road [12]. - **Talent Development**: Fostering a skilled workforce in carbon measurement through collaboration with universities and research institutions [12]. Main Procedures - **Unified Planning**: The market regulatory authority will oversee the overall planning and layout of the national carbon measurement center [13]. - **Application Process**: Encouraging qualified institutions to apply for establishing the carbon measurement center through provincial regulatory departments [13]. - **Approval and Acceptance**: The regulatory authority will guide and evaluate applications for the establishment of the carbon measurement center [14]. Support Measures - Regulatory departments are urged to prioritize the construction of the national carbon measurement center and share successful case studies to promote effective carbon measurement practices [15].

导读： 10x Genomics将以3000万美元对价股票+现金的形式收购单细胞生物学公司Scale Biosciences，并披露了2025年第二季度财务业绩。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 据Genomeweb报道，10xGenomics于周四收盘后表示，已签署最终协议， 将以3000万美元对价股票+现金的形式收购单细胞生物学公司 Scale Bioscience s 。 根据新闻稿，Scale的主要产品将继续在市场上提供。收购的财务条款未披露。 收购Scale Biosciences，扩展单细胞分析业务 此次收购旨在将Scale的组合索引和量子条形码技术整合到10x Genomics的Chromium平台中，有望使单细胞分析对全球研究人员更加便捷 和经济。 Scale Bio 由基因组学和生物信息学领域的专家创立，包括斯坦福大学的Garr y Nolan教授以及华盛顿大学的Jay Shendure和Cole Trapnel l教授， 收购完成后， 他们将作为顾问加入10x。 第二季度 仪器收入 为1450万美元，较去 ...

近日，国家自然科学基金公布2025年度青年科学基金项目（A类，含延续资助项目）和青年科学基金项目（B类）项目资助结果，多个单位相 继发布获批情况。 据不完全统计，目前 长江大学、华北理工大学、燕山大学、哈尔滨医科大学、中山大学、中南大学、山东第一医科大学、南方医科大学、深圳 大学、湖北大学、扬州大学、安徽农业大学、中国农科院、浙江农科院、中国科学院 等20余所高校机构公开披露了获批情况，其中包括 长江 大学、华北理工 等高校实现都实现了 历史性突破 ，首次获批该项目。具体如下： 导读： 近日，国家自然科学基金公布2025年度青年科学基金项目（A类，含延续资助项目）和青年科学基金项目（B类）项目资助结果，多个单位相继发布获批情 况，最新汇总情况如下： 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 | …… | | | | | --- | --- | --- | --- | | | | 青年科学基金项目 | B类资助 | | 序号 | 姓名 | 单位 | 项目名称 | | 1 | 马斌 | 扬州大学 | / | | 2 | 王周光 | 温州医 ...

QSight 500于2025年最新发布，适用于复杂食品基质中PFAS等痕量污染物的分析工作，它能够简化样品处理步骤，增加设备的正常运行时 间。该设备采用StayClean™自清洁技术，可降低污染风险，减少停机时间，帮助实验室实现"高通量、低维护"的运行效果。 Spotl ight Aurora傅里叶变换红外显微镜采用了全新的高分辨与宽场双光学成像系统，能更快速便捷地定位样品；其Wor k flow工作流显微分 析功能，可简化操作流程，提高分析效率；分体式组合红外显微镜的设计提供了更多灵活性，并能获取多维数据；该设备具备科研级性能与配 置，既满足专家深度操控的需求，也便于日常便捷操作。 导读： 近日，珀金埃尔默公司的QSight 500与Spotlight Aurora分别荣获Labmate 2025年度创新产品奖和最佳成像/光学产品奖。 特别提示 微信机制调整，点击顶部"仪器信息网" → 右上方"…" → 设为 ★ 星标，否则很可能无法看到我们的推送。 近日，珀金埃尔默的QSight 500 LC/MS/MS 与Spotl ight Aurora 傅里叶变换红外显微镜 分别荣获Labmate 2025年度创 ...

Core Viewpoint - Spectris plc reported a robust performance in the first half of 2025, with growth in orders and sales, alongside significant cost savings from efficiency initiatives. The board has recommended shareholders accept KKR's acquisition offer of £41.75 per share, which includes a declared interim dividend of 28 pence [1][3][20]. Financial and Operational Summary - Orders increased by 5% year-on-year, with a notable 15% growth in the second quarter [2][3]. - Sales grew by 8% year-on-year, with a 20% increase in the second quarter [3]. - Cost savings from the efficiency program exceeded £10 million in the first half, with expectations to surpass £30 million for the full year [3][6]. - Adjusted operating profit stood at £65.6 million, flat compared to the previous year, while statutory operating profit was £24.8 million, a 3% increase [3][27]. - Net debt was reported at £546 million, with a target leverage ratio of 1 to 2 times by the end of 2025 [3][6]. Acquisition Progress - KKR's acquisition proposal timeline includes: - June 5, 2025: KKR's initial proposal was rejected by the board [8]. - June 9, 2025: Advent made a conditional cash offer of £37.63 per share [9]. - June 23, 2025: Advent's offer was accepted, initiating exclusive due diligence [10]. - July 2, 2025: KKR submitted a revised offer of £40.00 per share [14]. - August 5, 2025: KKR's final offer of £41.75 per share was made, which the board recommended [18][20]. - Shareholder vote scheduled for August 27, 2025, with expected completion of the transaction in Q1 2026 [21][22]. Strategic Developments - The CEO highlighted the successful strategic transformation since 2018, focusing on high-growth, high-margin business segments [5][24]. - The efficiency program is on track to deliver over £30 million in cost savings, with two-thirds expected in the second half of 2025 [6][26]. - The integration of recent acquisitions is yielding significant synergies, enhancing revenue potential and operational efficiency [26][50]. Financial Performance Breakdown - Total orders for the first half reached £646.3 million, with a 5% year-on-year increase [28]. - Sales for the first half were £636.1 million, reflecting an 8% increase [27][28]. - The adjusted operating margin was 10.3%, with a cash conversion rate of 126% [27][47]. - The performance varied by sector, with strong growth in academic and materials sectors, while automotive and semiconductor sectors faced declines [29][30][42]. Regional and Sector Analysis - Orders in Europe and North America decreased, but growth in Asia partially offset this decline [31]. - Sales performance showed slight growth in Europe and Asia, while North America experienced a minor decline [32][34]. - The Spectris Scientific segment saw a 17% increase in orders and a 21% increase in sales, while the Spectris Dynamics segment experienced a 3% decline in orders [36][42].